Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the complete record of transactions filed by Lew Jennifer, Chief Financial Officer. Insider active across 2 companies, notably Annexon, Inc.. Aggregated, 20 disclosures have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €116k. Activity tracked since 27 May 2021. The latest transaction was disclosed on 2 March 2026 (Cession). Regulator: SEC (Form 4). The full history is free.
Companies and markets linked to Lew Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Lew Jennifer is Directeur Financier. She has 20 filings in total, and across the sampled recent filings from 2016-01-06 to 2026-03-04, the reported sell amount is EUR 115700 and the buy amount is EUR 0, with the dominant transaction nature indicated as Cession. Her recent filings concern Annexon, Inc. and ADURO BIOTECH, INC., with several sales at Annexon, Inc.